The Latest

The perioperative environment is one of the largest untapped sources of financial and operational improvement in health systems — and most organizations still aren’t capturing it. Unwarranted clinical variation, misaligned supply chain strategy and siloed decision-making quietly erode margins without…

An underrecognized, genetically inherited risk factor may be quietly accelerating cardiovascular disease in patients you’re already treating — and routine workups won’t catch it. Lipoprotein(a), or Lp(a), has an emerging and increasingly documented role in aortic stenosis and peripheral arterial…

Lp(a) is one of the most clinically meaningful — and most under-tested — cardiovascular risk factors in routine practice. Inaccurate assays, inconsistent reporting standards and disparities in testing across patient populations leave many at-risk patients undiagnosed and undertreated. This on-demand…

U.S. hospitals are under pressure from every direction — cost constraints, supply chain instability, cybersecurity threats and the push to integrate AI responsibly. The question isn’t whether to adapt. It’s how. In this webinar a global medtech CEO shares how…

Many DSOs have already invested in automation. Few have figured out how to manage it at scale. What worked across five locations often breaks at 50. As multi-site organizations grow, inconsistent workflows across patient and payer payment processes, limited visibility…

Controlled substance waste is one of the most overlooked cost centers in hospital pharmacy. Each waste event represents not just a lost dose, but lost nursing time, compliance overhead and real diversion risk. A recent multi-site study quantified the problem:…